CEPHALEXIN (cephalexin) by Molecular Devices is 12. Approved for the following infections caused by susceptible isolates of designated bacteria: • respiratory tract infection () • otitis media () • skin, skin structure infections () • bone infections () • genitourinary tract infections () to reduce the development of drug-resistant bacteria, maintain the effectiveness of cephalexin capsules and 18 more indications. First approved in 2005.
Drug data last refreshed 23h ago
12. CLINICAL PHARMACOLOGY 12.1 Mechanism of Action Cephalexin is a cephalosporin antibacterial drug [see ] . 12.3 Pharmacokinetics Absorption: Cephalexin is acid stable and may be given without regard to meals. Following doses of 250 mg, 500 mg, and 1 g, average peak serum levels of approximately…
Worked on CEPHALEXIN at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Oral Amoxicillin and Cephalexin PK/PD in Neonates
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
A Study of Cephalexin Liquid in Healthy Participants
A Study of Cephalexin Liquid for Pediatrics in Healthy Adults Participants
A Study of Cephalexin Suspension in Healthy Participants